Total study population | SARS-CoV-2 infection | Hospitalisation | ICU admission | COVID-19 deaths | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | n | % | ||
All | - | 4,301,995 | - | 74,371 | - | 1429 | - | 290 | - | 331 | - |
Age groups | 18–24 years | 457,238 | 10.6 | 11,499 | 15.5 | 24 | 1.7 | 1 | 0.3 | 0 | 0.0 |
25–34 years | 747,249 | 17.4 | 16,013 | 21.5 | 113 | 7.9 | 16 | 5.5 | 2 | 0.6 | |
35–44 years | 705,460 | 16.4 | 17,131 | 23.0 | 190 | 13.3 | 40 | 13.8 | 2 | 0.6 | |
45–54 years | 735,420 | 17.1 | 14,050 | 18.9 | 206 | 14.4 | 46 | 15.9 | 6 | 1.8 | |
55–64 years | 653,259 | 15.2 | 7440 | 10.0 | 202 | 14.1 | 63 | 21.7 | 22 | 6.6 | |
65–74 years | 540,898 | 12.6 | 4604 | 6.2 | 214 | 15.0 | 52 | 17.9 | 38 | 11.5 | |
75–84 years | 335,628 | 7.8 | 2557 | 3.4 | 301 | 21.1 | 59 | 20.3 | 103 | 31.1 | |
≥ 85 years | 126,843 | 2.9 | 1077 | 1.4 | 179 | 12.5 | 13 | 4.5 | 158 | 47.7 | |
Sex | Male | 2,160,307 | 50.2 | 37,098 | 49.9 | 791 | 55.4 | 196 | 67.6 | 185 | 55.9 |
Female | 2,141,688 | 49.8 | 37,273 | 50.1 | 638 | 44.6 | 94 | 32.4 | 146 | 44.1 | |
Underlying conditions | No risk group | 3,401,381 | 79.1 | 62,802 | 84.4 | 711 | 49.8 | 129 | 44.5 | 78 | 23.6 |
Medium risk | 788,954 | 18.3 | 10,247 | 13.8 | 524 | 36.7 | 115 | 39.7 | 180 | 54.4 | |
High risk | 111,660 | 2.6 | 1322 | 1.8 | 194 | 13.6 | 46 | 15.9 | 73 | 22.1 | |
Country of birth | Norway | 3202,876 | 74.5 | 46,501 | 62.5 | 791 | 55.4 | 170 | 58.6 | 247 | 74.6 |
Outside Norway | 802,615 | 18.7 | 25,579 | 34.4 | 506 | 35.4 | 103 | 35.5 | 34 | 10.3 | |
Unknown | 296,504 | 6.9 | 2291 | 3.1 | 132 | 9.2 | 17 | 5.9 | 50 | 15.1 | |
Crowding | Yes | 336,777 | 7.8 | 11,953 | 16.1 | 175 | 12.2 | 29 | 10.0 | 7 | 2.1 |
No | 3,728,263 | 86.7 | 57,206 | 76.9 | 1154 | 80.8 | 238 | 82.1 | 299 | 90.3 | |
Unknown | 236,955 | 5.5 | 5212 | 7.0 | 100 | 7.0 | 23 | 7.9 | 25 | 7.6 |